<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://www.pharmalinkconsulting.com/wp-content/plugins/sitemap/sitemap.xsl"?><!-- generator="wordpress/2.8" --><!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.1.6" --><!-- generated-on="December 6, 2011 2:49 am" --><!-- Debug: Total comment count: 0 --><urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://www.pharmalinkconsulting.com/</loc>
		<lastmod>2011-09-28T11:54:02+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
<!-- Debug: Start Postings --><!-- Debug: Priority report of postID 1702: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/careers/senior-regulatory-affairs-executive/</loc>
		<lastmod>2011-12-06T10:48:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/focus-areas/biotech/</loc>
		<lastmod>2011-09-28T11:50:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/case-studies/abbreviated-nda-preparation-2/</loc>
		<lastmod>2011-09-28T11:45:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/about-us/values/</loc>
		<lastmod>2011-09-28T11:43:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/careers/</loc>
		<lastmod>2011-09-28T11:39:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/permanent-staffing/</loc>
		<lastmod>2011-09-28T11:35:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/international/</loc>
		<lastmod>2011-09-28T11:33:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/contracting/</loc>
		<lastmod>2011-09-28T11:19:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/</loc>
		<lastmod>2011-09-28T11:04:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/about-us/</loc>
		<lastmod>2011-09-28T10:56:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 1653: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/careers/cmc-regulatory-affairs-consultants/</loc>
		<lastmod>2011-08-03T13:38:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1621: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/careers-us/regulatory-affairs-associate-positions/</loc>
		<lastmod>2011-07-15T00:37:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1511: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/careers/european-incl-israel-australia-and-nz-dermatology-regulatory-contractor/</loc>
		<lastmod>2011-06-03T14:18:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/permanent-staffing-requirements/</loc>
		<lastmod>2011-05-31T13:20:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 1376: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/uncategorized/regulatory-affairs-contract-opportunities-2/</loc>
		<lastmod>2011-05-25T17:02:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1481: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/careers-us/regulatory-affairs-consultants-%e2%80%93-all-levels/</loc>
		<lastmod>2011-05-19T19:20:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/requirements/</loc>
		<lastmod>2011-04-20T13:06:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/services/regulatory-operations/</loc>
		<lastmod>2011-04-07T12:01:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/services/clinical/</loc>
		<lastmod>2011-04-07T12:00:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/services/filing-expertise/</loc>
		<lastmod>2011-04-07T12:00:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/services/advertising-promotion-labeling/</loc>
		<lastmod>2011-04-07T11:59:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/services/regulatory/</loc>
		<lastmod>2011-04-07T11:59:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/services/postmarketing-maintenance/</loc>
		<lastmod>2011-04-07T11:57:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/services/</loc>
		<lastmod>2011-04-07T11:57:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/focus-areas/cosmetics/</loc>
		<lastmod>2011-04-07T11:56:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/focus-areas/veterinary/</loc>
		<lastmod>2011-04-07T11:56:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/focus-areas/nutraceuticals/</loc>
		<lastmod>2011-04-07T10:18:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/focus-areas/medical-devices/</loc>
		<lastmod>2011-04-07T10:17:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/focus-areas/generics/</loc>
		<lastmod>2011-04-07T09:21:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/focus-areas/otc/</loc>
		<lastmod>2011-04-07T09:20:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/focus-areas/</loc>
		<lastmod>2011-04-07T09:18:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/contact/</loc>
		<lastmod>2011-04-07T09:16:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 1432: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/newsletter/pharmalink-consulting-newsletter-summer-2010/</loc>
		<lastmod>2011-03-15T17:06:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1509: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/careers/french-speaking-regulatory-project-manager/</loc>
		<lastmod>2010-12-14T14:07:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1507: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/careers/dcpgenerics-contractor/</loc>
		<lastmod>2010-12-14T14:06:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1505: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/careers/regulatory-project-manager/</loc>
		<lastmod>2010-12-14T14:04:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1497: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/careers/therapeutic-regulatory-affairs-contractor-%e2%80%93-senior-associate-director-role-%e2%80%93-6-months5-days-per-week-based-south-england/</loc>
		<lastmod>2010-12-14T14:03:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1502: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/careers/associate-director-eu-regulatory-affairs-%e2%80%93-advertising-promotion-%e2%80%93-based-in-switzerland/</loc>
		<lastmod>2010-12-14T14:02:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/about-us/clients-testimonials/</loc>
		<lastmod>2010-07-28T15:03:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/questionaire-the-source/</loc>
		<lastmod>2009-12-09T19:34:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 1394: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/newsletter/pharmalink-consulting-newsletter-winter-2009/</loc>
		<lastmod>2009-12-02T01:04:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/corporate-responsibility/</loc>
		<lastmod>2009-10-20T20:54:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 1290: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/newsletter/pharmalink-consulting-newsletter-september-2009/</loc>
		<lastmod>2009-09-14T22:35:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1280: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://www.pharmalinkconsulting.com/worldwide-regulatory-affairs/mhra-pil-of-the-month-award-for-pharmalink-consulting/</loc>
		<lastmod>2009-08-28T16:17:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/services/non-clinical/</loc>
		<lastmod>2009-08-19T20:47:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/services/cmc-manufacturing/</loc>
		<lastmod>2009-08-19T20:47:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/case-studies/uk-marketing-authorization-application/</loc>
		<lastmod>2009-08-19T20:43:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/consulting/focus-areas/pharmaceutical/</loc>
		<lastmod>2009-07-29T23:40:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/case-studies/global-medical-device-manufacture-with-annual-turnover-of-circa/</loc>
		<lastmod>2009-07-29T12:34:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/error-page/</loc>
		<lastmod>2009-07-28T19:25:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/case-studies/european-product-compliance/</loc>
		<lastmod>2009-07-28T17:45:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/case-studies/quality-overall-summary-preparation/</loc>
		<lastmod>2009-07-28T17:45:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/case-studies/biosimilar-product-review/</loc>
		<lastmod>2009-07-28T17:45:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/message-sent/</loc>
		<lastmod>2009-07-28T16:38:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/case-studies/</loc>
		<lastmod>2009-07-27T15:54:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/privacy-policy/</loc>
		<lastmod>2009-07-25T01:44:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/about-us/awards-accreditations/</loc>
		<lastmod>2009-07-17T15:50:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/case-studies/certificate-of-suitability-review/</loc>
		<lastmod>2009-07-10T14:52:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.pharmalinkconsulting.com/blog/</loc>
		<lastmod>2009-06-30T21:34:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: End Postings --><!-- Debug: Start Custom Pages --><!-- Debug: End Custom Pages --><!-- Debug: Start additional URLs --><!-- Debug: End additional URLs --></urlset>
